Does your child suffer from
seasonal allergic rhinitis?

Principal Investigator: Isaac Melamed

Location: Centennial, CO

Description: Each allergy season, countless children suffer from the itchy, runny, and stuffy noses caused by Seasonal Allergic Rhinitis. Your child may be eligible to participate in a study for an investigational nasal spray designed to relieve these uncomfortable symptoms.

Qualifications Include: 
- Ages 6 to 11 years
- Have a history of Seasonal Allergic Rhinitis for at least 2 years
- Have a positive skin test to seasonal pollens/outdoor allergens (can during the study)

This study involves 3 office visits and one phone call. Physical and Nasal Exams, Study drug, and toys will be provided at no cost during the office visits, as will as up to $350 dollars compensation for time and travel.

For further information contact feel free to contact the study coordinator, Lauren Friedman, at 303-224-4700 or by email Lfriedman@1sthealthcenters.com

1st Health Centers
7286 S. Yosemite Street
Suite 180
Centennial, CO 80112
303-224-4700

Click here to volunteer for a research study. 


Meningitis vaccine

Description: 1st Health Centers is conducting a clinical research trial that is investigating the use of a vaccine to prevent against meningitis in the pediatric immunization series.

Qualifications Include: 
- Ages 7 months to 9 months, or 12 months old
- Generally healthy

Participation in the study involves two to four follow-up calls. All study-related visits and vaccines will be provided at no cost. Qualified participants will receive compensation for time and travel.  

For further information contact our study coordinator at 303-224-4700 or email Lrobinson@1sthealthcenters.com  

1st Health Centers
7286 S. Yosemite Street
Suite 180
Centennial, CO 80112
303-224-4700

Click here to volunteer for a research study. 


Pediatric Vaccination

Description: 1st Health Centers is currently conducting a clinical research evaluating a meningococcal vaccine for children.

Qualifications Include: 
- 2-5 years of age
- Healthy
- Previously received all recommended licensed vaccines
- Available for all study visits and telephone calls

Participation in the study involves 2-3 office visits and 2-3 telephone contacts. All study related vaccines and visits will be provided at no cost. Participants may be compensated for their time and travel.  

For further information contact our study coordinator at 303-224-4700 or email Lrobinson@1sthealthcenters.com  or  Lfriedman@1sthealthcenters.com 

1st Health Centers
7286 S. Yosemite Street
Suite 180
Centennial, CO 80112
303-224-4700

Click here to volunteer for a research study. 


Does your child suffer from eczema?

Description: 1st Health Centers is conducting a research study to evaluate the effectiveness of an investigational medication to treat eczema in children.

Qualifications Include: 
- Ages 1-8 years
- Have mild to moderate eczema
- Have food or environmental allergies

This study involves up to 5 visits over a course of 9 weeks. All study related medications and visits will be provided at no cost. Qualified participants will be compensated for their time and travel.

For further information contact our study coordinator at 303-224-4700 or email Lrobinson@1sthealthcenters.com 

1st Health Centers
7286 S. Yosemite Street
Suite 180
Centennial, CO 80112
303-224-4700

Click here to volunteer for a research study. 


Does your child have reflux (or GERD) symptoms that don’t go away with medication?

Description: If your child experiences the typical symptoms of reflux or GERD (vomiting, chest pain, chest burning, and/or difficulty swallowing), your child may have Eosinophilic Esophagitis (EE). 1st Health Centers is conducting a study of a new medication to treat EE in children.

Qualifications Include: 
- Ages 5 – 18 years old
- Have at least one of the following symptoms of active EE: Vomiting, spitting up, abdominal pain, chest pain/heartburn, difficulty swallowing
- Have tried acid reflux therapy without relief from symptoms

This study involves 6 visits over the course of 15 weeks. Qualified participants will receive financial compensation for time and travel.

For further information contact our study coordinator at 303-224-4700 or e-mail abeck@1sthealthcenters.com  

1st Health Centers
7286 S. Yosemite Street
Suite 180
Centennial, CO 80112
303-224-4700

Click here to volunteer for a research study. 


Gastroesophageal Reflux Disease (GERD)

Description: Gastroesophageal Reflux Disease (GERD) is when stomach contents (stomach acid and/or bile) come back up the esophagus and can cause inflammation or damage to the tissue. This is a result of improper closure of the valve at the top of the stomach.

Current Therapies: Current therapies for this age group include primarily with proton pump inhibitors and H2-blockers. The current therapies are metabolized by a very common pathway and can result in various drug interactions and increased or decreased metabolism of other medications.

Objective: To evaluate the efficacy and safety of an investigational pediatric micro-bead formulation of rabeprazole sodium 2 target dose levels in subjects 1-11 years of age with endoscopically proven GERD.

Study Length: Part 1: 14 weeks, Part 2: 24 weeks 
Randomization: Double-blind, randomized to study drug 0.5mg/kg or 1.0mg/kg in a 1:1 ratio 
Number of visits: Part 1: 5 in office visits and 2 telephone callsPart 2: 4 in office visits Visit content: Blood draws, pregnancy test (if applicable), EGD with biopsy, pHmetry (if indicated), physical assessments, treatment and symptom surveys/scales 
Patient Responsibilities: Patient caregiver must complete an e-diary during the entire study.

Major Inclusions: 
- Male or female age 1-11 years 
- History of at least 1 GERD symptom within 3 months prior to screening
- Positive EGD during screening

Major Exclusions: 
- History of eosinophilic esophagitis
- Have taken PPIs or H2-blockers within 3 days of random assignment
- Have taken sucralfate or any medication affecting GI motility including caffeine within 3 days before study entry
- H.pylori infection
- Current patrticipation or participation in the last 30 days in an investigational drug trial

Participants may receive study medication and physical assessments at no cost during the study. Participants who complete the entire study will be compensated $30 per completed study visit.

For further information contact Laura (303) 224-4694 or Chantal (303)224-4665 

1st Health Centers
7286 S. Yosemite Street
Suite 180
Centennial, CO 80112
303-224-4700

Click here to volunteer for a research study. 

 
 
RESPIRATORY
IMMUNE DEFICIENCY
AUTOIMMUNE
ALLERGY
NEUROLOGIC
PEDIATRICS
NEWS:
arrow
Download forms prior to your first visit. >>
 
 Health Care Professionals
 
 
CONTACT US
 Phone:
 
 Fax:
 Email:
(303) 773-9000 or
(877) 270-0491
(303) 770-1449
Click here >>
 Locations: South Office >>
North Office >>
Control your allergies
Do You Suffer Chronic